Definium Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +21.5% | +0.0% | – | – | +21.6% | -0.6% | -83.3% | -100.0% | |
| – | – | – | – | – | – | +476.8% | -67.9% | +13.0% | +9.2% | +18.8% | |
| – | +1,216.5% | -230.6% | – | – | +891.7% | -8.8% | -301.2% | – | -153.2% | – | |
| – | – | +7,041.9% | -51.4% | -70.0% | -100.0% | – | – | – | – | – | |
| – | -21.6% | -11,290.3% | – | -139.4% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -49.9% | +84.2% | |
| – | – | – | -92.8% | -7.6% | +33,435.5% | +2.2% | -40.2% | -63.0% | +1,058.9% | +5.6% | |
| – | – | -219.2% | – | -190.7% | – | -27.2% | -83.9% | -593.3% | – | -109.1% | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.